Sensidose AB - Company Review
Sensidose AB - Company ReviewSummary
Sensidose AB (Sensidose), is a pharmaceutical company which develops novel system for individualized dosing of pharmaceutical tablets. Its product includes MyFID, which is a smart dosing device for tablets. The device is developed based on proprietary microtablets Flexilev. Sensidose’s drug is used for the treatment of Parkinson’s disease and other indications such as pain, diabetes, and epilepsy. The device has an inbuilt alarm, delivers doses at the programmed time point, and registers all doses delivered and also disease symptoms. MyFID helps both the patient and physician to track treatment of doses delivered to the patient. Sensidose is headquartered in Sollentuna, Stockholm, Sweden.
This comprehensive company report of Sensidose AB provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.